Diagnosis and extension of giant cell arteritis. Contribution of imaging techniques

Presse Medicale

Volumn 41, Issue 10, 2012, Pages 948-954

  Blockmans, Daniel ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; IMMUNOSUPPRESSIVE AGENT; STEROID;

AORTA ARCH SYNDROME; AORTITIS; ARTERIAL WALL THICKENING; BIOPSY TECHNIQUE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DISEASE SEVERITY; DOPPLER ECHOGRAPHY; DRUG UPTAKE; FEVER; GIANT CELL ARTERITIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTERMETHOD COMPARISON; MALAISE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; RECEIVER OPERATING CHARACTERISTIC; RHEUMATIC POLYMYALGIA; SENSITIVITY AND SPECIFICITY; SHORT SURVEY; STEROID THERAPY; SYMPTOM; WEIGHT REDUCTION;

CEREBRAL ANGIOGRAPHY; DIAGNOSTIC IMAGING; DISEASE PROGRESSION; FLUORODEOXYGLUCOSE F18; GIANT CELL ARTERITIS; HUMANS; MAGNETIC RESONANCE IMAGING; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84866379164     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2012.05.014     Document Type: Short Survey

References (32)

1. Smetana G.W., Shmerling R.H. Does this patient have temporal arteritis. JAMA 2002, 287:92-101.
2. Hall S., Persellin S., Lie J.T., O'Brien P.C., Kurland L.T., Hunder G.G. The therapeutic impact of temporal artery biopsy. Lancet 1983, 2:1217-1220.
3. Brack A., Martinez-Taboada V., Stanson A., Goronzy J.J., Weyand C.M. Disease pattern in cranial and large-vessel giant cell arteritis. Arthritis Rheum 1999, 42:311-317.
4. Blockmans D., Knockaert D., Maes A., De Caestecker J., Stroobants S., Bobbaers H., et al. Clinical value of (18F)fluorodeoxyglucose positron emission tomography for patients with fever of unknown origin. Clin Infect Dis 2001, 32:191-196.
5. Blockmans D., Maes A., Stroobants S., et al. New arguments for a vasculitic nature of polymyalgia rheumatica using positron emission tomography. Rheumatology (Oxford) 1999, 38:444-447.
6. Blockmans D., Stroobants S., Maes A., et al. Positron emission tomography in giant cell arteritis and polymyalgia rheumatica: evidence for inflammation of the aortic arch. Am J Med 2000, 108:246-249.
7. Tato F., Hoffmann U. Clinical presentation and vascular imaging in giant cell arteritis of the femoropopliteal and tibioperoneal arteries. Analysis of four cases. J Vasc Surg 2006, 44:176-182.
8. Brodmann M., Lipp R.W., Passath A., et al. The role of 2-18F-fluoro-2-deoxy-D-glucose positron emission tomography in the diagnosis of giant cell arteritis of the temporal arteries. Rheumatology 2004, 43:241-242.
9. Blockmans D., De Ceuninck L., Vanderschueren S., et al. Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients. Arthritis Rheum 2006, 55:131-137.
10. Both M., Ahmadi-Simab K., Reuter M., et al. MRI and FDG-PET in the assessment of inflammatory aortic arch syndrome in complicated courses of giant cell arteritis. Ann Rheum Dis 2008, 67:1030-1033.
11. Janssen S.P., Comans E.H., Voskuyl A.E., et al. Giant cell arteritis: heterogeneity in clinical presentation and imaging results. J Vasc Surg 2008, 48:1025-1031.
12. Hautzel H., Sander O., Heinzel A., et al. Assessment of large-vessel involvement in giant cell arteritis with 18F-FDG-PET: introducing an ROC-analysis-based cut-off ratio. J Nucl Med 2008, 49:1107-1113.
13. Besson F.L., Parienti J.J., Bienvenu B., et al. Diagnostic performance of 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging 2011, 38:1764-1772.
14. Treglia G., Mattoli M.V., Leccisotti L., Ferraccioli G., Giordano A. Usefulness of whole body fluorine-18-fluorodeoxyglucose positron emission tomography in patients with large-vessel vasculitis: a systematic review. Clin Rheumatol 2011, 30:1265-1275.
15. Blockmans D., Coudyzer W., vanderschueren S., et al. Relationship between fluorodeoxyglucose uptake in the large vessels and late aortic diameter in giant cell arteritis. Rheumatology 2008, 47:1179-1184.
16. Schmidt W.A., Kraft H.E., Vorpahl K., Volker L., Gromnica-Ihle E.J. Color duplex ultrasonography in the diagnosis of temporal arteritis. N Engl J Med 1997, 337:1336-1342.
17. Salvarani C., Silingardi M., Ghirarduzzi A., Lo Scocco G., Machioni P., Bajocchi G., et al. Is duplex ultrasonography useful for the diagnosis of giant cell arteritis?. Ann Intern Med 2002, 137:232-238.
18. Karassa F.B., Matsagas M.I., Schmidt W.A., Ioannidis J.P. Diagnostic performance of ultrasonography for giant cell arteritis: a meta-analysis. Ann Intern Med 2005, 142:359-369.
19. Arida A., Kyprianou M., Kanakis M., Sfikakis P.P. The diagnostic value of ultrasonography-derived edema of the temporal artery wall in giant cell arteritis: a second meta-analysis. BMC Musculoskelet Disord 2010, 11:44.
20. Maldine C., Dépinay-Dhellemmes C., Tra T.T.S., et al. Limited value of temporal artery ultrasonography examinations for diagnosis of giant cell arteritis: analysis of 77 subjects. J Rheumatol 2010, 37:2326-2330.
21. Schmidt W.A., Moll A., Seifert A., et al. Prognosis of large-vessel giant cell arteritis. Rheumatology 2008, 47:1406-1408.
22. Schmidt W.A., Seifert A., Gromnica-Ihle E., et al. Ultrasound of proximal upper extremity arteries to increase the diagnostic yield in large-vessel giant cell arteritis. Rheumatology 2008, 47:96-101.
23. Evans J.M., O'Fallon W.M., Hunder G.G. Increased incidence of aortic aneurysms and dissection in giant cell (temporal) arteritis. A population-based study. Ann Intern Med 1995, 122:502-507.
24. Gonzalez-Gay M.A., Garcia-Porrua C., Pineiro A., et al. Aortic aneurysm and dissection in patients with biopsy-proven giant cell arteritis from northwestern Spain: a population-based study. Medicine (Baltimore) 2004, 83:335-341.
25. Nuenninghoff D.M., Hunder G.G., Chritianson T.J., et al. Incidence and predictors of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years. Arthritis Rheum 2003, 48:3522-3531.
26. Agard C., Barrier J.H., Dupas B., et al. Aortic involvement in recent-onset giant cell (temporal) arteritis: a case-control prospective study using helical aortic computed tomodensitometric scan. Arthritis Rheum 2008, 59:670-676.
27. Prieto-Gonzalez S., Arguis P., Garcia-Martinez A., et al. Large-vessel involvement in biopsy-proven giant cell arteritis: prospective study in 40 newly-diagnosed patients using CT angiography. Ann Rheum Dis 2012, 10.1136/annrheumdis-2011-200865.
28. Blockmans D., Bley T., Schmidt W. Imaging for large-vessel vasculitis. Curr Opin Rheumatol 2009, 21:19-28.
29. Bley T.A., Uhi M., Carew J., et al. Diagnostic value of high-resolution MR imaging in giant cell arteritis. Am J Neuroradiol 2007, 28:1722-1727.
30. Bley T.A., Geiger J., Jacobsen S., et al. High-resolution MRI for assessment of middle meningeal artery involvement in giant cell arteritis. Ann Rheum Dis 2009, 68:1369-1370.
31. Kissin E.Y., Merkel P.A. Diagnostic imaging in Takayasu's arteritis. Curr Opin Rheumatol 2004, 16:31-37.
32. Hunder G.G., Bloch D.A., Michel B.A., et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990, 33:1122-1128.